$WST
WEST PHARMACEUTICAL SERVICES INC

2018 Q1 Form 10-Q Financial Statement

#000010577018000015 Filed on May 08, 2018

View on sec.gov

Income Statement

Concept 2018 Q1 2017 Q1
Revenue $415.7M $387.7M
YoY Change 7.22% 7.07%
Cost Of Revenue $281.3M $253.5M
YoY Change 10.97% 6.16%
Gross Profit $134.4M $134.2M
YoY Change 0.15% 8.84%
Gross Profit Margin 32.33% 34.61%
Selling, General & Admin $68.30M $62.50M
YoY Change 9.28% 7.57%
% of Gross Profit 50.82% 46.57%
Research & Development $9.600M $10.30M
YoY Change -6.8% 9.57%
% of Gross Profit 7.14% 7.68%
Depreciation & Amortization $25.70M $22.60M
YoY Change 13.72% 4.63%
% of Gross Profit 19.12% 16.84%
Operating Expenses $77.90M $72.80M
YoY Change 7.01% 7.85%
Operating Profit $53.40M $60.50M
YoY Change -11.74% 101.67%
Interest Expense $1.900M $2.100M
YoY Change -9.52% -16.0%
% of Operating Profit 3.56% 3.47%
Other Income/Expense, Net $1.600M $800.0K
YoY Change 100.0%
Pretax Income $53.70M $59.50M
YoY Change -9.75% 114.03%
Income Tax $12.50M $2.200M
% Of Pretax Income 23.28% 3.7%
Net Earnings $43.60M $60.90M
YoY Change -28.41% 175.57%
Net Earnings / Revenue 10.49% 15.71%
Basic Earnings Per Share $0.59 $0.83
Diluted Earnings Per Share $0.58 $0.81
COMMON SHARES
Basic Shares Outstanding 73.90M shares 73.30M shares
Diluted Shares Outstanding 75.50M shares 74.90M shares

Balance Sheet

Concept 2018 Q1 2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $199.8M $169.4M
YoY Change 17.95% -4.88%
Cash & Equivalents $199.8M $169.4M
Short-Term Investments
Other Short-Term Assets $30.80M $46.10M
YoY Change -33.19% -5.73%
Inventory $194.4M $212.3M
Prepaid Expenses
Receivables $278.2M $224.8M
Other Receivables $0.00 $0.00
Total Short-Term Assets $743.5M $652.6M
YoY Change 13.93% 3.47%
LONG-TERM ASSETS
Property, Plant & Equipment $857.8M $782.8M
YoY Change 9.58% 6.87%
Goodwill $108.8M $103.5M
YoY Change 5.12% -2.08%
Intangibles $22.80M $23.10M
YoY Change -1.3% -10.47%
Long-Term Investments $76.50M $67.90M
YoY Change 12.67% 10.23%
Other Assets $21.90M $21.50M
YoY Change 1.86% -10.42%
Total Long-Term Assets $1.126B $1.081B
YoY Change 4.18% 4.18%
TOTAL ASSETS
Total Short-Term Assets $743.5M $652.6M
Total Long-Term Assets $1.126B $1.081B
Total Assets $1.870B $1.734B
YoY Change 7.85% 3.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $127.6M $106.1M
YoY Change 20.26% 8.82%
Accrued Expenses $52.90M $46.20M
YoY Change 14.5% -5.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $34.40M
YoY Change 1276.0%
Total Short-Term Liabilities $263.4M $256.5M
YoY Change 2.69% 6.39%
LONG-TERM LIABILITIES
Long-Term Debt $198.0M $194.2M
YoY Change 1.96% -15.38%
Other Long-Term Liabilities $37.70M $47.30M
YoY Change -20.3% -4.64%
Total Long-Term Liabilities $235.7M $241.5M
YoY Change -2.4% -13.47%
TOTAL LIABILITIES
Total Short-Term Liabilities $263.4M $256.5M
Total Long-Term Liabilities $235.7M $241.5M
Total Liabilities $564.3M $564.9M
YoY Change -0.11% -4.93%
SHAREHOLDERS EQUITY
Retained Earnings $1.190B $1.119B
YoY Change 6.33% 14.4%
Common Stock $18.80M $18.60M
YoY Change 1.08% 1.64%
Preferred Stock
YoY Change
Treasury Stock (at cost) $149.0M $65.80M
YoY Change 126.44% 414.06%
Treasury Stock Shares 1.700M shares 800.0K shares
Shareholders Equity $1.305B $1.169B
YoY Change
Total Liabilities & Shareholders Equity $1.870B $1.734B
YoY Change 7.85% 3.91%

Cashflow Statement

Concept 2018 Q1 2017 Q1
OPERATING ACTIVITIES
Net Income $43.60M $60.90M
YoY Change -28.41% 175.57%
Depreciation, Depletion And Amortization $25.70M $22.60M
YoY Change 13.72% 4.63%
Cash From Operating Activities $45.00M $20.70M
YoY Change 117.39% 590.0%
INVESTING ACTIVITIES
Capital Expenditures $28.00M $37.50M
YoY Change -25.33% -3.85%
Acquisitions
YoY Change
Other Investing Activities $700.0K -$2.800M
YoY Change -125.0% 600.0%
Cash From Investing Activities -$28.70M -$34.70M
YoY Change -17.29% -10.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $47.90M $26.90M
YoY Change 78.07% 195.6%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$56.90M -$21.80M
YoY Change 161.01% -66.51%
NET CHANGE
Cash From Operating Activities $45.00M $20.70M
Cash From Investing Activities -$28.70M -$34.70M
Cash From Financing Activities -$56.90M -$21.80M
Net Change In Cash -$40.60M -$35.80M
YoY Change 13.41% -64.45%
FREE CASH FLOW
Cash From Operating Activities $45.00M $20.70M
Capital Expenditures $28.00M $37.50M
Free Cash Flow $17.00M -$16.80M
YoY Change -201.19% -53.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q1 dei Amendment Flag
AmendmentFlag
false
CY2018Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2018Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2018Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2018Q1 dei Document Period End Date
DocumentPeriodEndDate
2018-03-31
CY2018Q1 dei Document Type
DocumentType
10-Q
CY2018Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000105770
CY2018Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
73577883 shares
CY2018Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2018Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2018Q1 dei Entity Registrant Name
EntityRegistrantName
WEST PHARMACEUTICAL SERVICES INC
CY2018Q1 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2018Q1 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
138100000 USD
CY2018Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
127600000 USD
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
253200000 USD
CY2018Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
290400000 USD
CY2018Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
278200000 USD
CY2017Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
6000000 USD
CY2018Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
13300000 USD
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
890800000 USD
CY2018Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
917500000 USD
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-117300000 USD
CY2018Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-95800000 USD
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
309300000 USD
CY2018Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
308500000 USD
CY2017Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
700000 USD
CY2018Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
700000 USD
CY2018Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
3700000 USD
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4400000 USD
CY2017Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3500000 USD
CY2018Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3400000 USD
CY2017Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
200000 shares
CY2018Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
700000 shares
CY2017Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2018Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
100000 USD
CY2017Q4 us-gaap Assets
Assets
1862800000 USD
CY2018Q1 us-gaap Assets
Assets
1869600000 USD
CY2017Q4 us-gaap Assets Current
AssetsCurrent
743500000 USD
CY2018Q1 us-gaap Assets Current
AssetsCurrent
743500000 USD
CY2017Q4 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
9400000 USD
CY2018Q1 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
12000000 USD
CY2017Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
300000 USD
CY2018Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
300000 USD
CY2017Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
4900000 USD
CY2018Q1 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
5000000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
203000000 USD
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
169400000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
235900000 USD
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
199800000 USD
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-33600000 USD
CY2018Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-36100000 USD
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.13
CY2018Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.14
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.25
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.25
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75200000 shares
CY2018Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75300000 shares
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
73900000 shares
CY2018Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
73600000 shares
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
18800000 USD
CY2018Q1 us-gaap Common Stock Value
CommonStockValue
18800000 USD
CY2017Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
68700000 USD
CY2018Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
65100000 USD
CY2017Q1 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1.00
CY2018Q1 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1.00
CY2017Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
7500000 USD
CY2018Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
6400000 USD
CY2017Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
33600000 USD
CY2018Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
22100000 USD
CY2018Q1 us-gaap Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized
ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
11500000 USD
CY2018Q1 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
18600000 USD
CY2018Q1 us-gaap Contract With Customer Liability Explanation Of Change
ContractWithCustomerLiabilityExplanationOfChange
1.5
CY2018Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
33900000 USD
CY2018Q1 us-gaap Contract With Customer Timing Of Satisfaction Of Performance Obligation And Payment
ContractWithCustomerTimingOfSatisfactionOfPerformanceObligationAndPayment
20.9
CY2017Q4 us-gaap Cost Method Investments
CostMethodInvestments
13400000 USD
CY2018Q1 us-gaap Cost Method Investments
CostMethodInvestments
13400000 USD
CY2017Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
253500000 USD
CY2018Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
281300000 USD
CY2018Q1 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
11400000 USD
CY2017Q4 us-gaap Debt Current
DebtCurrent
0 USD
CY2018Q1 us-gaap Debt Current
DebtCurrent
0 USD
CY2017Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
197000000 USD
CY2018Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
198000000 USD
CY2017Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
9900000 USD
CY2018Q1 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
9400000 USD
CY2017Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
8900000 USD
CY2018Q1 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
8300000 USD
CY2017Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
25700000 USD
CY2018Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
24900000 USD
CY2017Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
10400000 USD
CY2018Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
12300000 USD
CY2018Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
13400000 USD
CY2017Q4 us-gaap Deferred Tax Liabilities Undistributed Foreign Earnings
DeferredTaxLiabilitiesUndistributedForeignEarnings
9800000 USD
CY2017Q1 us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
-500000 USD
CY2018Q1 us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
-400000 USD
CY2017Q1 us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
-500000 USD
CY2018Q1 us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
-500000 USD
CY2017Q1 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
3400000 USD
CY2018Q1 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
3900000 USD
CY2017Q1 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
2600000 USD
CY2018Q1 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
2400000 USD
CY2017Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
1900000 USD
CY2018Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
1200000 USD
CY2017Q1 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
2700000 USD
CY2018Q1 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
2800000 USD
CY2017Q1 us-gaap Depreciation
Depreciation
22600000 USD
CY2018Q1 us-gaap Depreciation
Depreciation
25700000 USD
CY2018Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
10400000 USD
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.83
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.81
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.58
CY2017Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
2200000 USD
CY2018Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
4500000 USD
CY2017Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.036
CY2018Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.233
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
56200000 USD
CY2018Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
50600000 USD
CY2017Q4 us-gaap Equity Method Investments
EquityMethodInvestments
72400000 USD
CY2018Q1 us-gaap Equity Method Investments
EquityMethodInvestments
76500000 USD
CY2017 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-2400000 USD
CY2018Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
300000 USD
CY2017 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
700000 USD
CY2018Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
200000 USD
CY2016Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
8000000 USD
CY2017Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
4900000 USD
CY2018Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
5000000 USD
CY2017Q4 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
500000 USD
CY2018Q1 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
3700000 USD
CY2017Q4 us-gaap Foreign Currency Contracts Liability Fair Value Disclosure
ForeignCurrencyContractsLiabilityFairValueDisclosure
5100000 USD
CY2018Q1 us-gaap Foreign Currency Contracts Liability Fair Value Disclosure
ForeignCurrencyContractsLiabilityFairValueDisclosure
2400000 USD
CY2017Q4 us-gaap Goodwill
Goodwill
107700000 USD
CY2018Q1 us-gaap Goodwill
Goodwill
108800000 USD
CY2017Q1 us-gaap Gross Profit
GrossProfit
134200000 USD
CY2018Q1 us-gaap Gross Profit
GrossProfit
134400000 USD
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
59500000 USD
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
53700000 USD
CY2017Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3600000 USD
CY2018Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2400000 USD
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2200000 USD
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12500000 USD
CY2017Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
3200000 USD
CY2018Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
2700000 USD
CY2017Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1600000 shares
CY2018Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1600000 shares
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
21700000 USD
CY2018Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
22800000 USD
CY2017Q1 us-gaap Interest Expense
InterestExpense
2100000 USD
CY2018Q1 us-gaap Interest Expense
InterestExpense
1900000 USD
CY2017Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
94800000 USD
CY2018Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
83600000 USD
CY2017Q4 us-gaap Inventory Net
InventoryNet
215200000 USD
CY2018Q1 us-gaap Inventory Net
InventoryNet
215700000 USD
CY2018Q1 us-gaap Inventory Net
InventoryNet
194400000 USD
CY2017Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
88600000 USD
CY2018Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
92000000 USD
CY2017Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
31800000 USD
CY2018Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
40100000 USD
CY2017Q1 us-gaap Investment Income Net
InvestmentIncomeNet
300000 USD
CY2018Q1 us-gaap Investment Income Net
InvestmentIncomeNet
600000 USD
CY2017Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
85800000 USD
CY2018Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
89900000 USD
CY2017Q4 us-gaap Liabilities
Liabilities
582900000 USD
CY2018Q1 us-gaap Liabilities
Liabilities
564300000 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1862800000 USD
CY2018Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1869600000 USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
279500000 USD
CY2018Q1 us-gaap Liabilities Current
LiabilitiesCurrent
263400000 USD
CY2017Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
19900000 USD
CY2018Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
16800000 USD
CY2017Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
201500000 USD
CY2018Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
198600000 USD
CY2017Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
197000000 USD
CY2018Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
198000000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-21800000 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-56900000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-34700000 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-28700000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
20700000 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
45000000 USD
CY2018Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
60500000 USD
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
53400000 USD
CY2017Q4 us-gaap Other Assets Current
OtherAssetsCurrent
39200000 USD
CY2018Q1 us-gaap Other Assets Current
OtherAssetsCurrent
37600000 USD
CY2018Q1 us-gaap Other Assets Current
OtherAssetsCurrent
30800000 USD
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
23400000 USD
CY2018Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
21900000 USD
CY2017Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
300000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
0 USD
CY2017Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
100000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
0 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
20600000 USD
CY2017Q1 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
1700000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
2200000 USD
CY2017Q1 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
800000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
800000 USD
CY2017Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
5900000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
20000000 USD
CY2017Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
7800000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
21500000 USD
CY2017Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
100000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
700000 USD
CY2017Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
-100000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
-300000 USD
CY2017Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
77000000 USD
CY2018Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
69600000 USD
CY2018Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
63300000 USD
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
42600000 USD
CY2018Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
35600000 USD
CY2018Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
37700000 USD
CY2017Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
63800000 USD
CY2018Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
25600000 USD
CY2017Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
800000 USD
CY2018Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1600000 USD
CY2017Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1000000 USD
CY2018Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
300000 USD
CY2017Q1 us-gaap Other Restructuring Costs
OtherRestructuringCosts
0 USD
CY2018Q1 us-gaap Other Restructuring Costs
OtherRestructuringCosts
1200000 USD
CY2017Q1 us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
0 USD
CY2018Q1 us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
200000 USD
CY2017Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-2800000 USD
CY2018Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
700000 USD
CY2017Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
26900000 USD
CY2018Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
47900000 USD
CY2017Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
9500000 USD
CY2018Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
10400000 USD
CY2017Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3800000 USD
CY2018Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3700000 USD
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
37500000 USD
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28000000 USD
CY2017Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
2200000 USD
CY2018Q1 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
2300000 USD
CY2017Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
53400000 USD
CY2018Q1 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
55000000 USD
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
3000000 shares
CY2018Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
3000000 shares
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2017Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
1000000 USD
CY2018Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
1100000 USD
CY2017Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-100000 USD
CY2018Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
CY2017Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
18100000 USD
CY2018Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4000000 USD
CY2017Q1 us-gaap Profit Loss
ProfitLoss
60900000 USD
CY2018Q1 us-gaap Profit Loss
ProfitLoss
43600000 USD
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1745800000 USD
CY2018Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1775300000 USD
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
855000000 USD
CY2018Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
857800000 USD
CY2018Q1 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-900000 USD
CY2017Q1 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
600000 USD
CY2018Q1 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
0 USD
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10300000 USD
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9600000 USD
CY2017Q1 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
0 USD
CY2018Q1 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
3300000 USD
CY2018Q1 us-gaap Restructuring Charges
RestructuringCharges
3300000 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1178200000 USD
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1222800000 USD
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1189600000 USD
CY2017Q1 us-gaap Sales Revenue Net
SalesRevenueNet
387700000 USD
CY2018Q1 us-gaap Sales Revenue Net
SalesRevenueNet
415700000 USD
CY2017Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
62500000 USD
CY2018Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
68300000 USD
CY2017Q1 us-gaap Severance Costs1
SeveranceCosts1
0 USD
CY2018Q1 us-gaap Severance Costs1
SeveranceCosts1
2000000 USD
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3500000 USD
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3400000 USD
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.007
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.197
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0270
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
3898075 shares
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
459364 shares
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
19.93
CY2018Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
89.56
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y7M
CY2018Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
6500000 USD
CY2017Q4 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
800000 shares
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1279900000 USD
CY2018Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1305300000 USD
CY2018Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
88.74
CY2017Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1300000 shares
CY2018Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
1700000 shares
CY2018Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
540000 shares
CY2017Q4 us-gaap Treasury Stock Value
TreasuryStockValue
109100000 USD
CY2018Q1 us-gaap Treasury Stock Value
TreasuryStockValue
149000000 USD
CY2018Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
47900000 USD
CY2017Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
700000 USD
CY2018Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
700000 USD
CY2017Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74900000 shares
CY2018Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75500000 shares
CY2017Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73300000 shares
CY2018Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73900000 shares
CY2018Q1 wst Contractwith Customer Asset Increase Decrease
ContractwithCustomerAssetIncreaseDecrease
-1100000 USD
CY2017Q1 wst Developmentandlicensingincome
Developmentandlicensingincome
400000 USD
CY2018Q1 wst Developmentandlicensingincome
Developmentandlicensingincome
200000 USD
CY2017Q1 wst Other Income Expense
OtherIncomeExpense
-900000 USD
CY2018Q1 wst Other Income Expense
OtherIncomeExpense
-3100000 USD
CY2018Q1 wst Tax Cutsand Jobs Actof2017 Incomplete Accounting Changein Tax Rate Provisional Income Tax Expense
TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpense
300000 USD

Files In Submission

Name View Source Status
0000105770-18-000015-index-headers.html Edgar Link pending
0000105770-18-000015-index.html Edgar Link pending
0000105770-18-000015.txt Edgar Link pending
0000105770-18-000015-xbrl.zip Edgar Link pending
ex311q12018.htm Edgar Link pending
ex312q12018.htm Edgar Link pending
ex321q12018.htm Edgar Link pending
ex322q12018.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wst-20180331.xml Edgar Link completed
wst-20180331.xsd Edgar Link pending
wst-20180331_cal.xml Edgar Link unprocessable
wst-20180331_def.xml Edgar Link unprocessable
wst-20180331_lab.xml Edgar Link unprocessable
wst-20180331_pre.xml Edgar Link unprocessable
wst10q33118.htm Edgar Link pending